Sweetech (Drug Discovery) Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.58M
- Investors
-
3
Sweetech (Drug Discovery) General Information
Description
Developer of medical applications designed to improve human health. The company produces and markets sugar via innovative and patented fermentation processes to offer, on an industrial scale, several oligosaccharides with high potential for health applications, enabling clients to target the production and sales of rare and high-added-value oligosaccharides through the development of innovative and patented fermentation processes.
Contact Information
Website
www.sweetech.frCorporate Office
- 2 Avenue de Clairefontaine
- Building A apartment 32
- 31490 Leguevin
- France
Corporate Office
- 2 Avenue de Clairefontaine
- Building A apartment 32
- 31490 Leguevin
- France
Sweetech (Drug Discovery) Timeline
Sweetech (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 08-Jan-2026 | $2.58M | Completed | Generating Revenue | ||
| 2. Angel (individual) | 06-Oct-2023 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2022 | $56.5K | $56.5K | Completed | Generating Revenue |
Sweetech (Drug Discovery) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sweetech (Drug Discovery) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sweetech (Drug Discovery) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sweetech (Drug Discovery) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Iron Hands Capital | PE/Buyout | Minority | ||
| Toulouse Tech Transfer | Corporation | Minority |
Sweetech (Drug Discovery) FAQs
-
When was Sweetech (Drug Discovery) founded?
Sweetech (Drug Discovery) was founded in 2021.
-
Where is Sweetech (Drug Discovery) headquartered?
Sweetech (Drug Discovery) is headquartered in Leguevin, France.
-
What is the size of Sweetech (Drug Discovery)?
Sweetech (Drug Discovery) has 10 total employees.
-
What industry is Sweetech (Drug Discovery) in?
Sweetech (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Sweetech (Drug Discovery) a private or public company?
Sweetech (Drug Discovery) is a Private company.
-
What is Sweetech (Drug Discovery)’s current revenue?
The current revenue for Sweetech (Drug Discovery) is .
-
How much funding has Sweetech (Drug Discovery) raised over time?
Sweetech (Drug Discovery) has raised $2.88M.
-
Who are Sweetech (Drug Discovery)’s investors?
Bpifrance, Iron Hands Capital, and Toulouse Tech Transfer have invested in Sweetech (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
